NDC 57894-225-99
INLEXZO 225 mg/1
gemcitabine intravesical · SYSTEM
INLEXZO is a system containing gemcitabine intravesical at a strength of 225 mg/1. Manufactured by Janssen Biotech, Inc.
Key Facts
- Brand Name
- INLEXZO
- Generic Name
- gemcitabine intravesical
- NDC Code (Package)
57894-225-99- NDC Code (Product)
57894-225- Manufacturer
- Janssen Biotech, Inc
- Strength
- 225 mg/1
- Dosage Form
- SYSTEM
- Route
- INTRAVESICAL
- Marketing Status
- Application #
- NDA219683
- Drug Class
- Nucleoside Metabolic Inhibitor [EPC]
- Marketing Start
- 09/14/2025
Recall History
No Recall HistoryView Full Drug Page
INLEXZO — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.